Literature DB >> 14758083

Seeing strangers or announcing "danger": galectin-3 in two models of innate immunity.

Sachiko Sato1, Julie Nieminen.   

Abstract

Recent investigations on the molecular mechanisms by which our immune system recognizes infections and initiates defense against those infections have led to the proposition of two models explaining the way our innate immunity system functions; the self-nonself model and the Danger model. In this review, the roles of galectin-3 in innate immunity against infections--host-pathogen interactions--will be discussed. We will shed light on the potential contribution of a beta-galactoside binding mammalian lectin, galectin-3 as a molecule implicated in innate immunity from the angle of both the self-nonself model and the Danger model.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 14758083     DOI: 10.1023/B:GLYC.0000014089.17121.cc

Source DB:  PubMed          Journal:  Glycoconj J        ISSN: 0282-0080            Impact factor:   2.916


  91 in total

Review 1.  Galectins as modulators of cell adhesion.

Authors:  R C Hughes
Journal:  Biochimie       Date:  2001-07       Impact factor: 4.079

Review 2.  Toll-like receptors and innate immunity.

Authors:  R Medzhitov
Journal:  Nat Rev Immunol       Date:  2001-11       Impact factor: 53.106

Review 3.  An innate sense of danger.

Authors:  P Matzinger
Journal:  Semin Immunol       Date:  1998-10       Impact factor: 11.130

4.  Basic fibroblast growth factor fused to a signal peptide transforms cells.

Authors:  S Rogelj; R A Weinberg; P Fanning; M Klagsbrun
Journal:  Nature       Date:  1988-01-14       Impact factor: 49.962

5.  Role of chemokines and formyl peptides in pneumococcal pneumonia-induced monocyte/macrophage recruitment.

Authors:  I Fillion; N Ouellet; M Simard; Y Bergeron; S Sato; M G Bergeron
Journal:  J Immunol       Date:  2001-06-15       Impact factor: 5.422

6.  Galectin-3 inhibits granulocyte-macrophage colony-stimulating factor (GM-CSF)-driven rat bone marrow cell proliferation and GM-CSF-induced gene transcription.

Authors:  W Krugluger; L G Frigeri; T Lucas; M Schmer; O Förster; F T Liu; G Boltz-Nitulescu
Journal:  Immunobiology       Date:  1997-06       Impact factor: 3.144

7.  Galectin-3 is a novel substrate for human matrix metalloproteinases-2 and -9.

Authors:  J Ochieng; R Fridman; P Nangia-Makker; D E Kleiner; L A Liotta; W G Stetler-Stevenson; A Raz
Journal:  Biochemistry       Date:  1994-11-29       Impact factor: 3.162

8.  Galectin-3 down-regulates IL-5 gene expression on different cell types.

Authors:  I Cortegano; V del Pozo; B Cárdaba; B de Andrés; S Gallardo; A del Amo; I Arrieta; A Jurado; P Palomino; F T Liu; C Lahoz
Journal:  J Immunol       Date:  1998-07-01       Impact factor: 5.422

9.  Maintenance of granulocyte numbers during acute peritonitis is defective in galectin-3-null mutant mice.

Authors:  C Colnot; M A Ripoche; G Milon; X Montagutelli; P R Crocker; F Poirier
Journal:  Immunology       Date:  1998-07       Impact factor: 7.397

10.  Recognition of human histocompatibility leukocyte antigen (HLA)-E complexed with HLA class I signal sequence-derived peptides by CD94/NKG2 confers protection from natural killer cell-mediated lysis.

Authors:  F Borrego; M Ulbrecht; E H Weiss; J E Coligan; A G Brooks
Journal:  J Exp Med       Date:  1998-03-02       Impact factor: 14.307

View more
  46 in total

Review 1.  Introduction to galectins.

Authors:  Hakon Leffler; Susanne Carlsson; Maria Hedlund; Yuning Qian; Francoise Poirier
Journal:  Glycoconj J       Date:  2002       Impact factor: 2.916

2.  Immunohistochemical identification of notochordal markers in cells in the aging human lumbar intervertebral disc.

Authors:  Christoph Weiler; Andreas G Nerlich; Rainer Schaaf; Beatrice E Bachmeier; Karin Wuertz; Norbert Boos
Journal:  Eur Spine J       Date:  2010-04-07       Impact factor: 3.134

Review 3.  Expanding the universe of cytokines and pattern recognition receptors: galectins and glycans in innate immunity.

Authors:  Juan P Cerliani; Sean R Stowell; Iván D Mascanfroni; Connie M Arthur; Richard D Cummings; Gabriel A Rabinovich
Journal:  J Clin Immunol       Date:  2010-12-24       Impact factor: 8.317

4.  Co-purification of Mac-2 binding protein with galectin-3 and association with prostasomes in human semen.

Authors:  Ashley S Block; Sarika Saraswati; Cheryl F Lichti; Maha Mahadevan; Alan B Diekman
Journal:  Prostate       Date:  2010-10-28       Impact factor: 4.104

5.  Host-soluble galectin-1 promotes HIV-1 replication through a direct interaction with glycans of viral gp120 and host CD4.

Authors:  Christian St-Pierre; Hiroshi Manya; Michel Ouellet; Gary F Clark; Tamao Endo; Michel J Tremblay; Sachiko Sato
Journal:  J Virol       Date:  2011-08-31       Impact factor: 5.103

Review 6.  Roles of galectins in infection.

Authors:  Gerardo R Vasta
Journal:  Nat Rev Microbiol       Date:  2009-06       Impact factor: 60.633

Review 7.  Innate immunity against molecular mimicry: Examining galectin-mediated antimicrobial activity.

Authors:  Connie M Arthur; Seema R Patel; Amanda Mener; Nourine A Kamili; Ross M Fasano; Erin Meyer; Annie M Winkler; Martha Sola-Visner; Cassandra D Josephson; Sean R Stowell
Journal:  Bioessays       Date:  2015-12       Impact factor: 4.345

8.  Galectin-3 gene inactivation reduces atherosclerotic lesions and adventitial inflammation in ApoE-deficient mice.

Authors:  Maurice Nachtigal; Abdul Ghaffar; Eugene P Mayer
Journal:  Am J Pathol       Date:  2007-12-21       Impact factor: 4.307

9.  Galectin-7 in the control of epidermal homeostasis after injury.

Authors:  Gaëlle Gendronneau; Sukhvinder S Sidhu; Delphine Delacour; Tien Dang; Chloé Calonne; Denis Houzelstein; Thierry Magnaldo; Françoise Poirier
Journal:  Mol Biol Cell       Date:  2008-10-01       Impact factor: 4.138

10.  Pathogenic roles of CD14, galectin-3, and OX40 during experimental cerebral malaria in mice.

Authors:  Miranda S Oakley; Victoria Majam; Babita Mahajan; Noel Gerald; Vivek Anantharaman; Jerrold M Ward; Lawrence J Faucette; Thomas F McCutchan; Hong Zheng; Masaki Terabe; Jay A Berzofsky; L Aravind; Sanjai Kumar
Journal:  PLoS One       Date:  2009-08-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.